Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Sep 28, 2007 3:00pm
188 Views
Post# 13489928

New Clinical Trial Starts for Transition

New Clinical Trial Starts for Transition Transition is starting it's first of 2 Phasel Trials for G1 tomorrow with the second to begin immediately after and both expected to get Data by years end........these trials are being done to increase Transitions flexibility with the Gastrin Based Technologies going into the G1 Stand Alone Phasell Trial slated to be started in January. After which a G1+Byetta trial will then start as well. Moving forward as planned ........
Bullboard Posts